|
¯f¨Ò³ø§i
¡@¡@¥|·³¤CӤ몺¨kµ£©óÀ¦¨à®É´Á§Y±`±`¦]¬°«æ©Ê²Ó¤ä®ðºÞª¢¦í°|¡A«á¨Ó³Q¶EÂ_¥X¦³®ð³Ý¥H¤Î¹L±Ó©Ê»óª¢ªº¯e¯f¡C¯f±w¦bªù¶E©w´Á°lÂÜ¡A¨Ã¥H¤ä®ðºÞÂX±i¾¯¡B§Ü²Õ´Ói©MÃþ©T¾JªvÀø¡C¹L±ÓìÀËÅçµo²{¦³¹Ðú@¹L±Óªº±¡§Î¡A¦Ó¥¤é¤pªB¤Í¦³«y¹Â¤Î¬y»ó¤ôªº¯gª¬¡C¯f±w¦b¨âÓ¤ë«e¶}©l¦³«y¹Â¥[¼@ªº±¡§Î¡A¦bÃhºÃ¦³Åð¼ßµß·P¬Vªº¥i¯à©Ê¤U¡Aªù¶Eµ¹¤©¬õÅð¯ÀªvÀø¡A¦ý¯f±¡¤´µM¤Ï¤ÏÂÐÂСC±q¤J°|¨â¤Ñ«e¶}©l¯f±wªº«y¹Â¡B³Ý»ï§ó¥[ÄY«¡A¨Ã¥i¥Hµo²{©úÅ㪺¦Ø¶¡¥W³´¡AÁöµM¥i¥H¥Î®ðÃú¾÷ªº¤ä®ðºÞÂX±i¾¯¼È®É½w¸Ñ¯f±¡¡A¦ý¬O´XÓ¤p®É«á¦P¼Ëªº¯gª¬¤S¦A´_µo¡C¦b³y³X«æ¶E¼Æ¦¸¤§«á¡A¯f±w³Q¦w±Æn¦í°|ªvÀø¡C´N¦b¤pªB¤Í¥½ö¶i¦æª`®g°w¯d¸m³N®É¡A¬ðµMµo¥Í±³¡¼é¬õ¡BµoÖæªº±¡§Î¡Cºò«æµ¹¤©®ñ®ð±¸nµL®Ä«á¡A¦©¤W±¸nµ¹¤©¥¿À£©I§l¤´¤£¨£§ïµ½¡A¥Bµo¥Í¤ß¸õ¯ß·i¶}©l´îºC¡Cºò«æ´¡¤J®ðºÞ¤ººÞ¤Îµ¹¤©¥¿À£©I§l¡A°£¤FÅé¥~¤ßŦ«ö¼¯¥~¦P®É¨Ãµ¹¤©µÇ¤W¸¢¯À¥H¤ÎºÒ»Ä²B¶uª`®g¡A¨ä¶¡¥ç¦³¤ß«ÇŸ°Êªº±¡ªp¨Ã¤©¥H¦h¦¸¹qÀ»¡CÂà¨ì¥[Å@¯f©Ð«á¡AªÍ³¡®ðÅé¶i¤JÁnµ¤´µM¤£¨Î¡A¦å²G®ñ®ð¿@«×¤]¤£Ã©w¡C¦b«·s¸m´«¸û²Êªº®ðºÞ¤ººÞ¡]5.0¡¡^¨Ã¸m©ñ¤ñ¸û²`¡]¤ñì¥ý¦h¨â¤½¤À¡^ªº±¡ªp«á¡A©I§lªº±¡ªp¤~¦³§ïµ½¡C¦b²z¾ÇÀˬd¤è±¡A¯f±wªº²´¥Ö¦³¤ô¸~ªº²{¶H¡AÀV³¡¸~µÈ¡AÀV³¡©M«e¯ÝªºÀR¯ß¦³¦±±iªº±¡§Î¡C¨â°¼©I§lÁnµ¹ïºÙ¦ý²ÊÁW¡F¤ßŦµLÂøµ¡C¨â°¼¤WªÏ¦³»´·L¤ô¸~¡A¦ý¬O¨â°¼¤UªÏ«h¥¿±`¡C
¡@¡@¯Ý³¡X¥ú¥i¥H¬Ý¨ì¤@ÓÅܼeªº¤WÁa»JµÄ¡A¤ßŦ¤j¤p©MªºªÍ³¡³£¬°¥¿±`¡C©â¦åÀˬd¥Dnµo²{¦³°ª¦å¹[¡]7.2meq/l¡^
¡B°ª¦åÁC(13.2mg/dl¡^¥H¤Î°ª§¿»Ä¦å¯g¡]14.4mg/dl¡^¡A¨ä¥Lªº¥Í¤ÆÀËÅç©M¦å²yp¼Æ¬°¥¿±`¡C¦bÃhºÃ¬OÁa»JµÄ¸~½Fªº±¡§Î¤U¡A°µ°©Åè¤Á¤ùÀˬd¡Aµ²ªG¬°¥¿±`¡A¨Ã¨S¦³¬Ý¨£²§±`ªº²ÓM¡C¦]¬°¯f±w§e²{¸£¦ºªº±¡ªp¡A¥H¤Î¦Ò¼{¨ä³Â¾Kªº¦MÀI©Ê¡A¨S¦³¶i¤@¨B°w¹ï¸~½F°µ¤Á¤ù¤Î¿n·¥ªº¤Æ¾ÇªvÀø©Î©ñ®g½uªvÀø¡C
°Q½×¡G
¡@¡@®ð³Ý¯fµ£¦X¨ÖÁa¹j¸~½F¬O¨u¨£ªº¡A¦ý¬OYµLªk¨Æ¥ý¶EÂ_¥X®ð³Ý¯fµ£ªºÁa¹j¸~½F¡A«h¯fµ£¥i¯à·|¦]¦¹³à¥¢¥Í©R¡A©Ò¥HChest
PAªºÀˬd¹ïÃþ©T¾J¤ÏÀ³¤í¨Îªº¯fµ£¬O¦³¥²nªº¡CÁa»JµÄ¸~½Fªºªí²{±`±`¬O«D±`»´·Lªº¡A¦Ó¥B¤]±`©M¨ä¥Lªº±`¨£ªº©I§l¹D¯e¯fÃø¥HŲ§O¶EÂ_¡A¤×¦³¬ÆªÌ¡A¦³¬Û·í¦hªº¯f±w¦bÁ{§É¤W¨Ã¨S¦³¥ô¦óªº¯gª¬¡A¦Ó¥B¦b²z¾ÇÀˬd¤W¤]¨S¦³¯S®íªº²§±`µo²{¡C¥»¤å¤¤©Ò°Q½×±wªÌªºÁ{§Éªí²{¤]¨Ã¤£¬O°ß¤@ªº®×¨Ò¡A1990¦~¦b¤é¥»¤]´¿¦³¤@Ó¬Û·íÃþ¦üªº¯f¨Ò¡C쥻¨S¦³¯S®í¯gª¬ªº¤T·³¨k«Ä¡A¤]¬O¦b¥½ö¶i¦æª`®g®É¡A¦P¼Ë©¿µMµo¥Í©I§lµ~¢¤Î¤ßŦ°±¤îªº±¡§Î¡AÁö¸g«æ±Ï¦ý¬O¤´µM¦º¤`¡C«á¨Ó¸g¹L¯f²z¸Ñå¤~µo²{±wªÌ¦³¤@Ó¤jÁa»JµÄ¸~½F¡FP¦ºì¦]»P¥´°w®É±j¢¨kµ£¥½ö¡A¦Ó¾ÉPÁa»J¸~½FÀ£¢®ðºÞ©M¤ßŦ«á¡A³y¦¨¤ßªÍµLªk¹B§@¥i¯à¬ÛÃö¡C
¡@¡@°£¤F®ð³Ý¤§¥~¡A¦³¬Û·í¦hªº¯e¯f¤]·|¦³³Ý»ïÁn¥H¤Îstridorªºªí²{¡A¦ÓÁa»JµÄ¸~½F´N¬O¨ä¤¤¤§¤@¡CÁöµM¤åÄm¤W³ø§i¡A§Y¨ÏÁa»JµÄ¸~½F¬Û·íªº¤j¡A¬Û·í¦h³o¼Ëªº¯f±w¤´µM¦nªø¤@¬q®É¶¡¨S¦³¯gª¬¡A¥u¯à¦bX¥ú¤Wµo²{²§¼Ë¡C¦ý¬O¦³¤@¨Ç¼xª¬¤´µM¥i¥H´£¿ô§ÚÌ¥h¦´Áµo²{³o¼Ëªº¯e¯f¡C³q±`¯gª¬©M¸~½F¥»¨ªº¤j¤p¡B¦ì¸m¡BÅܤjªº³t«×¡B©P¾D¾¹©xªº«I¥Ç©ÎÀ£¢µ{«×¦³Ãö¡C¦b©I§l¹D¤è±¡A¦]¬°¸~½FÀ£¢®ðºÞ¡B¤ä®ðºÞ¬Æ¦ÜªÍ¹ê½è¡A·|¤Þµo°®«y¡B³Ý»ï¡Bstridor¡B©I§l§xÃø©M«y¦å¡C¦³®É·|¤Þµo³æ°¼©Ê©ÎÂù°¼©Êªº¤U©I§l¹Dªý¶ë©Ê®ð¸~¡BªÍ¶ò³´¡BªÍª¢¡C¥t¥~¡A¦³®É¸~½FÀ£¢¨ì³ïªð¯«¸g¡AÁÙ·|¦³Ánµ¨F°×ªº±¡§Î¡C¦b¸zG¹Dªº¯gª¬¤è±¡A±`±`·|À£¢¨ì¹¹D¡A¯gª¬¦³¹Ã¦R¡B§]Ã`§xÃøªº±¡§Î¡C¯«¸g¾Ç¤è±¡A¦³®É·|¦³¯ÝµÄ¤ºÁôÁôªº¤£¾A·P¡F¦³®É¦]¬°¦Ø¶¡¯«¸gÀ£¢¡A·|¦³º¦µh·P¡F¦³®É¦]¬°¯á¬W«I¥Ç¦Ó¦³ªÓK°©¤§¶¡ªº¯kµh·P¡F¦pªG¦³ÀV³¡¯«¸g¸`ªº«I¥Ç¡A«h·|¦³Horner¯gÔ¸sªºªí²{¡C¦b¦åºÞ¤è±¡A¦pªGÀ£¢¨ì¤j¦åºÞ¡A¨Ò¦pÀ£¢¨ì¤WµÄ¤jÀR¯ß¡A±`·|¦³¤WµÄÀR¯ß¯gÔ¸sªºªí²{¡ÐÀY³¡¡BÀV³¡¥H¤Î¤WªÏªºÀR¯ß¦±±i¤Î¤ô¸~¡]¥»¯f¤H§Y¦³Ãþ¦üªºªí²{¡^¡C¤Ö¼ÆÀ£¢¨ì¤UµÄÀR¯ßªº¯f±w¡A·|¦³¤UªÏªº¤ô¸~±¡§Î¡C¨ä¾l¤Ö¨£ªº¯gª¬«h¥]§tµo¿N¡BÅé«´î»´¡B³h¦å¥H¤Î¹¼¤¤£®¶¡C
¡@¡@¤åÄm´¿¸g³ø§i¹L50¨Ò¨àµ£Áa»JµÄ¸~½Fªº¯f±w¡A¨ä¤¤¦³30¦ì¦³©I§l¹Dªº¯gª¬¡C·í¤¤9¦ì¯f±w¦³©I§lµ~¢ªº²{¶H¡]¥]§t¦³ºÝ§¤©I§l¥H¤Îstridor¡^¡C30¦ì¯f±w¤¤¦³13¦ì¦b©ñ®g½uÀˬd¤¤¥i¥H¨£¨ì®ðºÞ©Î¤ä®ðºÞªºÀ£¢¡C¥H¹q¸£Â_¼h°µÀˬd®É¡A¥i¥H¨£¨ì¯f±wªº®ðºÞ¾îºI±©M¥¿±`¬Û¸û¦³35¢H¨ì93¢H¤£µ¥ªº´î¤Ö¡C¨ä¤¤µLªk¤Á°£ªº´c©Ê¸~½F¥]§t¤F²O¤Ú½F¡BHodgkin
¯e¯f¡B´c©Ê¾î¯¾¦Ù¦×½F¥H¤Î¯«¸g¥À²ÓM½F¡C
¡@¡@¥t¥~¡AÁa»JµÄ¸~½F¯f±w±`·|¦³ªÍ¥\¯à¤Wªº»Ùê¡A³o¥]§tªý¶ë©Ê¥H¤Î¨î©Êªº»Ùê¡C¦Óªý¶ëªºµ{«×³q±`©M¸~½F¤j¤p¦¨¤ñ¨Ò¡C¤]¦³³ø§i«ü¥X¡ANon-Hodgkin
lymphoma¤ñHodgkin disease§ó®e©ö³y¦¨©I§l¹Dªºªý¶ë¡C³oÃþªº©I§l¹Dªý¶ë¬O¨S¦³¿ìªk¦]¬°§Ü²Õ´Óiªºµ¹¤©¦ÓÀò±o½w¸Ñªº¡C¦P®Éȱoª`·Nªº¬O¡A¥þ¨³Â¾K¹ï©óÁa»JµÄ¸~½F¯f±w¨Ó»¡¡A±`±`·|¤Þ°_P¦º©Êªº©I§l¹Dªý¶ë¡A¬OÓ·¥«×¦MÀIªº³B¸m¡C¤åÄm¤W¤w¸g³ø§i¹L¬Û·í¦h¨Ò¦]¬°¥þ¨³Â¾K³y¦¨µLªk®¾±Ïªº¥þ©I§l¹Dªý¶ëP¦ºªº®×¨Ò¡C§ón¯S§Oª`·Nªº¬O¡A§Y¨Ï¦b³o¼Ëªº¯f¤H¥ß¨èµ¹¤©®ðºÞ´¡ºÞ¡B¥¿À£©I§l¤Î¤j¶qÃþ©T¾JªvÀø¡A¤´µM¦³¬Û·í¤j¤ñ¨Òªº¯f±w¤´µM«æ±ÏµL®Ä¦Ó¦º¤`¡C¤]¥¿¦]¬°³o¼Ë¤jªº¦MÀI©Ê¡A¦pªG¯f±w»Ýn°µ¤Á¤ùÀˬd¡A¥²¶·¥H§½³¡³Â¾K¬I¦æ¡C¦pªG¥²¶·n°µ¥þ¨³Â¾K¡A«h¥²¶·µ¥¨ì¸~½FÀ£¢ªº±¡§Î¤w¸g¦]¤Æ¾ÇªvÀø©Î©ñ®g©ÊªvÀø½w¸Ñ«á¤~¥i¥H¬I¦æ¡C
¡@¡@Á`¦Ó¨¥¤§¡A®ð³Ý¯fµ£¦X¨ÖÁa¹j¸~½F¬O¤Q¤À¨u¨£ªº¡C¦ÓÁa»JµÄ¸~½F¬OÓ¤£®e©ö±qÁ{§É¤W¶EÂ_ªº¯e¯f¡A¨Ã¥B¦³®ÉÔ·|¥H«D±`¦M«æªº±¡ªpªí²{¡A©Ò¥H§Ú̦b¥¤é·ÓÅU±wªÌ®É¡A¹ï©ó¤@¨ÇÃø¥H±±¨îªº®ð³Ý¨Ã¯gª¬¡B©I§l¹D¯e¯f¡B¤£´M±`ªºÁ{§ÉÅܤƩMªí¼x¶·¯S§Oª`·N¡A¥²n®É¤]n»²¥H¼v¹³¾ÇªºÀˬd¡A¥H±Æ°£¦pÁa»JµÄ¸~½Fµ¥¯e¯f©Ò³y¦¨¤§©I§l¹Dªý¶ë©Ê¯e¯f¡C
References:
1. Yamashita M, Chin I, Horigome H,
et al: Sudden fatal cardiac arrest in a child with an unrecognized
anterior mediastinal mass: Resuscitation 1990; 19(2):175-7
2. Azizkhan RG, Dudgeon DL, Buck JR, et al: Life-threatening airway
obstruction as a complication to the management of mediastinal masses
in children: Journal of Pediatric Surgery1985; 20(6):816-22
3. Pullerits J, Holzman R: Anaesthesia for patients with mediastinal
masses: Canadian Journal of Anaesthesia 1989; 36(6):681-8
4. Monleau M, Alibeu JP, Stieglitz P: Respiratory obstruction during
anesthesia in cases of mediastinal malignant lymphoma: Annales Francaises
d Anesthesie et de Reanimation. 2(4):308-11, 1983.
5. Mackie AM, Watson CB: Anaesthesia and mediastinal masses. A case
report and review of the literature. Anaesthesia 1984 39(9):899-903
|